Aziz Sawaf
2023
In 2023, Aziz Sawaf earned a total compensation of $1.4M as Senior Vice President, Chief Financial Officer at Theravance Biopharma.
Compensation breakdown
| Bonus | $9,000 |
|---|---|
| Non-Equity Incentive Plan | $126,000 |
| Salary | $448,500 |
| Stock Awards | $803,200 |
| Total | $1,386,700 |
Sawaf received $803.2K in stock awards, accounting for 58% of the total pay in 2023.
Sawaf also received $9K in bonus, $126K in non-equity incentive plan and $448.5K in salary.
Rankings
In 2023, Aziz Sawaf's compensation ranked 857th out of 2,997 executives tracked by ExecPay. In other words, Sawaf earned more than 71.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 857 out of 2,997 | 71st |
Division Manufacturing | 500 out of 1,641 | 70th |
Major group Chemicals And Allied Products | 341 out of 909 | 63rd |
Industry group Drugs | 332 out of 872 | 62nd |
Industry Pharmaceutical Preparations | 223 out of 630 | 65th |
Source: SEC filing on April 5, 2024.
Sawaf's colleagues
We found two more compensation records of executives who worked with Aziz Sawaf at Theravance Biopharma in 2023.